Last update 01 Nov 2024

PJ1-01

Overview

Basic Info

Drug Type
Synthetic peptide
Synonyms
Target
HMGB1
Mechanism
HMGB1 inhibitors(High Mobility Group Protein B1 inhibitors)
Therapeutic Areas
Nervous System DiseasesCardiovascular DiseasesCongenital Disorders+ [2]
Active Indication
Cerebral InfarctionChronic liver diseaseEpidermolysis Bullosa+ [2]
Inactive Indication-
Originator Organization
StemRIM, Inc.StemRIM, Inc.
Active Organization
Niigata UniversityNiigata UniversityStemRIM, Inc.StemRIM, Inc.Shionogi & Co., Ltd.Shionogi & Co., Ltd.
+ [2]
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

100 Clinical Results associated with PJ1-01
Login to view more data
100 Translational Medicine associated with PJ1-01
Login to view more data
100 Patents (Medical) associated with PJ1-01
Login to view more data
100 Deals associated with PJ1-01
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Cerebral InfarctionPhase 2
JP
Shionogi & Co., Ltd.Shionogi & Co., Ltd.
12 Oct 2022
Cerebral InfarctionPhase 2
JP
StemRIM, Inc.StemRIM, Inc.
12 Oct 2022
Chronic liver diseasePhase 2
JP
Niigata UniversityNiigata University
12 Oct 2022
Chronic liver diseasePhase 2
JP
StemRIM, Inc.StemRIM, Inc.
12 Oct 2022
Epidermolysis BullosaPhase 2
JP
StemRIM, Inc.StemRIM, Inc.
12 Oct 2022
Epidermolysis BullosaPhase 2
JP
Osaka UniversityOsaka University
12 Oct 2022
Osteoarthritis, KneePhase 2
JP
StemRIM, Inc.StemRIM, Inc.
12 Oct 2022
Osteoarthritis, KneePhase 2
JP
Hirosaki UniversityHirosaki University
12 Oct 2022
CardiomyopathiesPhase 1
JP
Osaka UniversityOsaka University
12 Oct 2022
CardiomyopathiesPhase 1
JP
StemRIM, Inc.StemRIM, Inc.
12 Oct 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free